W
WAVEMAN · COMPANY
PHVS · Pharvaris N.V.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

PHVS

Pharvaris N.V.
PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0001830487
FORM 144 · 14☆ WATCH
INSIDER NET · 180D
-$12.4M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
74
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-
CONVERSIONS · 180D
26
codes C/M, not in net · $1.0M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$12.4M over 180 days
-$5.5M over 90 days
below 86% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
74 funds added or opened last quarter
more than 55% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
1.8% of shares outstanding short · 3.8 days to cover · settled 2026-07-31
below 65% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$12.4M across 11 people in 180 days.
74 funds added or opened positions in the latest 13F quarter, of 125 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +56.7%
+56.7%12M
-7%+17%+42%+66%2025-092025-102025-122026-032026-052026-072026-09 2026-06-30 · Schikan Johannes Gerardus Christiaan Petrus sold $1.1M2026-06-30 · Lesage Anne sold $1.1M2026-06-30 · Lesage Anne sold $988.9K2026-04-30 · Schikan Johannes Gerardus Christiaan Petrus sold $860.5K2026-04-09 · Modig Berndt sold $641.7K2026-04-30 · Lesage Anne sold $581.0K2026-04-30 · Lesage Anne sold $544.7K2026-06-26 · Lu Peng sold $499.8K2026-04-30 · Lu Peng sold $453.6K2026-05-01 · Lu Peng sold $422.9K2026-06-25 · Lu Peng sold $399.6K2026-05-21 · Nassif David W. sold $303.1K2026-05-15 · Souverijns Wim sold $299.2K2026-05-20 · Bjork Elisabeth sold $293.2K2026-05-21 · Monges Viviane sold $292.8K2026-06-29 · Lesage Anne sold $290.9K2026-05-15 · Abele Stefan Andreas sold $260.9K2026-06-29 · Lesage Anne sold $245.2K2026-06-29 · Schikan Johannes Gerardus Christiaan Petrus sold $241.4K2026-04-22 · Lu Peng sold $210.4K2026-04-22 · Schikan Johannes Gerardus Christiaan Petrus sold $210.3K2026-04-22 · Lesage Anne sold $210.3K2026-05-22 · Nijdam Anna sold $169.1K2026-05-15 · Glassman Robert sold $159.1K2026-05-15 · Glassman Robert sold $139.2K2026-06-25 · Lu Peng sold $119.3K2026-04-29 · Schikan Johannes Gerardus Christiaan Petrus sold $115.2K2026-04-29 · Lu Peng sold $112.2K2026-04-30 · Lesage Anne sold $112.0K2026-04-29 · Lesage Anne sold $111.3K2026-04-29 · Lesage Anne sold $111.2K2026-06-29 · Schikan Johannes Gerardus Christiaan Petrus sold $84.2K2026-06-04 · Nijdam Anna sold $82.4K2026-06-29 · Lesage Anne sold $80.8K2026-06-25 · Lesage Anne sold $80.8K2026-07-13 · Modig Berndt sold $80.2K2026-08-14 · Modig Berndt sold $79.7K2026-06-15 · Modig Berndt sold $68.0K2026-05-18 · Modig Berndt sold $67.0K2026-04-16 · Modig Berndt sold $65.6K2026-05-21 · Nijdam Anna sold $56.0K2026-04-30 · Schikan Johannes Gerardus Christiaan Petrus sold $20.8K2026-08-14 · Berndt B.A,E. Modig filed to sell $78.0K2026-07-13 · Berndt B.A,E. Modig filed to sell $80.4K2026-06-30 · ANNE SIMONNE J. LESAGE filed to sell $967.4K2026-06-30 · GrayMatters Consulting B.V. filed to sell $1.1M2026-06-30 · Hans H. Schikan filed to sell $1.1M2026-06-29 · ANNE SIMONNE J. LESAGE filed to sell $282.3K2026-06-29 · GrayMatters Consulting B.V. filed to sell $238.0K2026-06-29 · Hans H. Schikan filed to sell $234.3K2026-06-26 · PENG LU filed to sell $489.5K2026-06-25 · ANNE SIMONNE J. LESAGE filed to sell $76.6K2026-06-25 · GrayMatters Consulting B.V. filed to sell $76.6K2026-06-25 · PENG LU filed to sell $499.4K2026-06-25 · Hans H. Schikan filed to sell $79.9K2026-06-18 · PENG LU filed to sell $10.0K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $12.4M sold by insiders over 180 days, 74 funds added last quarter, $5.2M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Pharvaris N.V. insiders sold a net $12.4M of stock across 50 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Modig Berndt
Chief Executive Officer
SELL
2026-08-14
2,292.0
$79.7K
Modig Berndt
Chief Executive Officer
SELL
2026-07-13
2,292.0
$80.2K
Lesage Anne
Chief Early Development
SELL
2026-06-30
27,872.0
$988.9K
Lesage Anne
Chief Early Development
SELL
2026-06-30
30,703.0
$1.1M
Schikan Johannes Gerardus Christiaan Petrus
Director
SELL
2026-06-30
30,712.0
$1.1M
50 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 45 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
FMR LLC
6,565,272.0 sh
$227.0M
GENERAL ATLANTIC, L.P.
6,550,757.0 sh
$226.5M
Foresite Capital Management IV, LLC
4,778,581.0 sh
$165.2M
venBio Partners LLC
4,643,430.0 sh
$160.6M
VIKING GLOBAL INVESTORS LP
3,653,310.0 sh
$126.3M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Berndt B.A,E. Modig
FILED 2026-08-14
$78.0K
Berndt B.A,E. Modig
FILED 2026-07-13
$80.4K
ANNE SIMONNE J. LESAGE
FILED 2026-06-30
$967.4K
GrayMatters Consulting B.V.
FILED 2026-06-30
$1.1M
Hans H. Schikan
FILED 2026-06-30
$1.1M
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
ALPS Medical Breakthroughs ETF
$1.6M POSITION · AS OF 2026-02-28
1.2%
Small Cap Stock Trust
$568.7K POSITION · AS OF 2026-03-31
0.2%
iShares MSCI Netherlands ETF
$693.1K POSITION · AS OF 2026-02-28
0.2%
Invesco Nasdaq Biotechnology ETF
$101.9K POSITION · AS OF 2026-02-28
0.1%
Health Sciences Trust
$251.4K POSITION · AS OF 2026-03-31
0.1%
T. Rowe Price Innovation Leaders ETF
$10.0K POSITION · AS OF 2026-03-31
0.1%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
NET INCOME$-175.7M$-134.2M$-100.9M$-76.3M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →